Cargando…
Efficacy and safety of biologic agents for the treatment of osteoarthritis: a meta-analysis of randomized placebo-controlled trials
BACKGROUND: We aimed to evaluate the efficacy and safety of biologic agents targeting three main cytokines, that is, nerve growth factor (NGF), interleukin-1 (IL-1), and tumor necrosis factor-α (TNF-α), for osteoarthritis (OA) treatment. METHODS: Databases (PubMed, Embase, and Cochrane Library) and...
Autores principales: | Meng, Fanqiang, Li, Hui, Feng, Haoran, Long, Huizhong, Yang, Zidan, Li, Jiatian, Wang, Yuqing, Xie, Dongxing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908403/ https://www.ncbi.nlm.nih.gov/pubmed/35282570 http://dx.doi.org/10.1177/1759720X221080377 |
Ejemplares similares
-
Latest insights in disease-modifying osteoarthritis drugs development
por: Li, Shengfa, et al.
Publicado: (2023) -
Regenerative medicine for early osteoarthritis
por: Im, Gun-Il, et al.
Publicado: (2023) -
Emerging molecular biomarkers in osteoarthritis pathology
por: Sandhu, Amit, et al.
Publicado: (2023) -
Circulating microRNAs differentiate fast-progressing from slow-progressing and non-progressing knee osteoarthritis in the Osteoarthritis Initiative cohort
por: Ali, Shabana Amanda, et al.
Publicado: (2022) -
Repurposed and investigational disease-modifying drugs in osteoarthritis (DMOADs)
por: Oo, Win Min, et al.
Publicado: (2022)